These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 19528278)

  • 21. Comparative bioavailability of cefuroxime axetil suspension formulations administered with food in healthy subjects.
    Mendes GD; Borges A; de Cássia Val L; Patni AK; Reyar S; Monif T; Sereno D; Orellana AM; De Nucci G
    Arzneimittelforschung; 2010; 60(2):101-5. PubMed ID: 20329659
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multicenter surveillance of antimicrobial resistance of Streptococcus pyogenes, Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis to 14 oral antibiotics.
    Hsueh PR; Huang WK; Shyr JM; Lau YJ; Liu YC; Luh KT
    J Formos Med Assoc; 2004 Sep; 103(9):664-70. PubMed ID: 15361938
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of population pharmacokinetic modeling and Monte Carlo simulation to describe the pharmacodynamic profile of cefditoren in plasma and epithelial lining fluid.
    Lodise TP; Kinzig-Schippers M; Drusano GL; Loos U; Vogel F; Bulitta J; Hinder M; Sörgel F
    Antimicrob Agents Chemother; 2008 Jun; 52(6):1945-51. PubMed ID: 17485507
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bioequivalence evaluation of 2 brands of cefuroxime axetil 250 mg tablets in healthy human volunteers.
    Pistos C; Michalea S; Kalovidouris M; Kontopoulos G; Georgarakis M
    Int J Clin Pharmacol Ther; 2004 Jul; 42(7):367-72. PubMed ID: 15605688
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Population pharmacokinetics and use of Monte Carlo simulation to evaluate currently recommended dosing regimens of ciprofloxacin in adult patients with cystic fibrosis.
    Montgomery MJ; Beringer PM; Aminimanizani A; Louie SG; Shapiro BJ; Jelliffe R; Gill MA
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3468-73. PubMed ID: 11709326
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative pharmacokinetics of oral ceftibuten, cefixime, cefaclor, and cefuroxime axetil in healthy volunteers.
    Nix DE; Symonds WT; Hyatt JM; Wilton JH; Teal MA; Reidenberg P; Affrime MB
    Pharmacotherapy; 1997; 17(1):121-5. PubMed ID: 9017772
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the pharmacokinetics and pharmacodynamic profile of carumonam in cystic fibrosis patients and healthy volunteers.
    Bulitta JB; Duffull SB; Landersdorfer CB; Kinzig M; Holzgrabe U; Stephan U; Drusano GL; Sörgel F
    Diagn Microbiol Infect Dis; 2009 Oct; 65(2):130-41. PubMed ID: 19748423
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A multicenter, randomized study comparing the efficacy and safety of intravenous and/or oral levofloxacin versus ceftriaxone and/or cefuroxime axetil in treatment of adults with community-acquired pneumonia.
    File TM; Segreti J; Dunbar L; Player R; Kohler R; Williams RR; Kojak C; Rubin A
    Antimicrob Agents Chemother; 1997 Sep; 41(9):1965-72. PubMed ID: 9303395
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the efficacy and safety of faropenem daloxate and cefuroxime axetil for the treatment of acute bacterial maxillary sinusitis in adults.
    Siegert R; Berg O; Gehanno P; Leiberman A; Martinkenas JL; Nikolaidis P; Arvis P; Alefelder M; Reimnitz P
    Eur Arch Otorhinolaryngol; 2003 Apr; 260(4):186-94. PubMed ID: 12709801
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cefuroxime axetil.
    Dellamonica P
    Int J Antimicrob Agents; 1994 Mar; 4(1):23-36. PubMed ID: 18611587
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetic-Pharmacodynamic Target Attainment Analyses To Determine Optimal Dosing of Ceftazidime-Avibactam for the Treatment of Acute Pulmonary Exacerbations in Patients with Cystic Fibrosis.
    Bensman TJ; Wang J; Jayne J; Fukushima L; Rao AP; D'Argenio DZ; Beringer PM
    Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28784670
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cefuroxime axetil in the treatment of sinusitis. A review.
    Pakes GE; Graham JA; Rauch AM; Collins JJ
    Arch Fam Med; 1994 Feb; 3(2):165-75. PubMed ID: 7994439
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Population Pharmacokinetics and Pharmacodynamics of Meropenem in Nonobese, Obese, and Morbidly Obese Patients.
    Chung EK; Cheatham SC; Fleming MR; Healy DP; Kays MB
    J Clin Pharmacol; 2017 Mar; 57(3):356-368. PubMed ID: 27530916
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical comparison of cefuroxime axetil and amoxicillin/clavulanate in the treatment of patients with secondary bacterial infections of acute bronchitis.
    Henry D; Ruoff GE; Rhudy J; Puopolo A; Drehobl M; Schoenberger J; Giguere G; Collins JJ
    Clin Ther; 1995; 17(5):861-74. PubMed ID: 8595638
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of Penicillin G in Preterm and Term Neonates.
    Padari H; Metsvaht T; Germovsek E; Barker CI; Kipper K; Herodes K; Standing JF; Oselin K; Tasa T; Soeorg H; Lutsar I
    Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29463540
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Susceptibility of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis to 17 oral antimicrobial agents based on pharmacodynamic parameters: 1998-2001 U S Surveillance Study.
    Jacobs MR; Bajaksouzian S; Windau A; Good CE; Lin G; Pankuch GA; Appelbaum PC
    Clin Lab Med; 2004 Jun; 24(2):503-30. PubMed ID: 15177851
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo correlates for Streptococcus pneumoniae penicillin resistance in acute otitis media.
    Gehanno P; Lenoir G; Berche P
    Antimicrob Agents Chemother; 1995 Jan; 39(1):271-2. PubMed ID: 7695322
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of two types of Indian breakfast on bioavailability of cefuroxime axetil.
    Vasu S; Adithan C; Shashindran CH; Asad M; Koumaravelou K; Topno I
    Indian J Med Res; 2000 Sep; 112():104-8. PubMed ID: 11094856
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bone penetration of amoxicillin and clavulanic acid evaluated by population pharmacokinetics and Monte Carlo simulation.
    Landersdorfer CB; Kinzig M; Bulitta JB; Hennig FF; Holzgrabe U; Sörgel F; Gusinde J
    Antimicrob Agents Chemother; 2009 Jun; 53(6):2569-78. PubMed ID: 19307356
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibiotic susceptibility in Streptococcus pneumoniae, Haemophilus influenzae and Streptococcus pyogenes in Pakistan: a review of results from the Survey of Antibiotic Resistance (SOAR) 2002-15.
    Zafar A; Hasan R; Nizamuddin S; Mahmood N; Mukhtar S; Ali F; Morrissey I; Barker K; Torumkuney D
    J Antimicrob Chemother; 2016 May; 71 Suppl 1(Suppl 1):i103-9. PubMed ID: 27048578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.